StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CHARAN-R.BK$18.00+0.00%
Fair $18.00+0.0%

CHARAN-R.BK

Charan Insurance Public Company Limited

Financial Services / Insurance - Property & CasualtyThailand

$18.00

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $18.00Fund rank 20/100 · Data gapFallback financials|
SA 20/D
F-Score: 4/9

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 20.0/100

Data gap 20/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 7/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

20/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified.
Thesis & Journal · CHARAN-R.BKLocal privado en este navegador · Charan Insurance Public Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$216M

P/E

7.1x

↓

EV/EBITDA

N/A

•

ROE

5.2%

↓

Gross Margin

N/A

•

Debt/Equity

N/A

•
52-Week Range$18
$20$20

TradingView lightweight chart

CHARAN-R.BK price, volumen y niveles de valoración

Último $20.00Periodo -69.9%
Fair value: $18.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-5.4%

FCF CAGR

—

FCF margin

-6.4%

FCF / Net income

-0.85x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $406.9M · net income $30.7M · FCF $-26.0M

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

7.5%-7.0% pts

FCF margin

-6.4%+9.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$406.9M$406.9M$331.0M$313.1M$481.4M
Net Income$30.7M$30.7M$-2.0M$27.4M$69.8M
EPS2.552.55-0.172.285.82
Net Margin7.5%7.5%-0.6%8.7%14.5%
Balance Sheet
Current Ratio20.8020.80———
Cash Flow
Free Cash Flow$-26.0M$-26.0M$62.6M$32.0M$-74.3M
Returns
ROE5.2%5.2%-0.4%4.8%12.0%
Valuation
P/E7.067.06—14.044.68
P/B0.370.370.450.680.56
Growth & Yield
Revenue Growth22.9%22.9%5.7%-35.0%—
EPS Growth1600.0%1600.0%-107.5%-60.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-14.4%

fácil

EPS terminal req.

$1.60

Spread vs growth

1614.4%

5Y implied EPS CAGR

-5.4%

fácil

EPS terminal req.

$1.93

Spread vs growth

1605.4%

10Y implied EPS CAGR

2.0%

fácil

EPS terminal req.

$3.11

Spread vs growth

1598.0%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +0.0%

Total return

+0.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.17 → 2.55

Residual

+0.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+0.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.